Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Yizhen Guo, Lai Wei, Sandip H. Patel, et al.
Clinical Lung Cancer (2022) Vol. 23, Iss. 4, pp. 345-355
Open Access | Times Cited: 25

Showing 25 citing articles:

The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
Deniz Can Güven, Taha Koray Şahin, Enes Erul, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 133
Serum Albumin as an Independent Predictor of Long-Term Survival in Patients with Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab
Shinsuke Suzuki, Yukie Taguchi, Takuro Kitabayashi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2456-2456
Open Access | Times Cited: 7
The Association Between Neutrophil‐Percentage‐to‐Albumin Ratio (NPAR) and Mortality Among Individuals With Cancer: Insights From National Health and Nutrition Examination Survey
Xinyang Li, Meng Wu, Minxin Chen, et al.
Cancer Medicine (2025) Vol. 14, Iss. 2
Open Access
The prognostic value of lactate dehydrogenase/albumin ratio in extranodal natural killer/T cell lymphoma
Na Li, You Feng, Xin Chen, et al.
Research Square (Research Square) (2025)
Closed Access
Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade
Ming Zheng
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005670-e005670
Open Access | Times Cited: 16
Performance of nutritional and inflammatory markers in patients with pancreatic cancer
Jie-Nan Lu, Lu-Sha Zhou, Shuai Zhang, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 8, pp. 1021-1032
Open Access | Times Cited: 3
Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma
Tai-Jan Chiu, Tai‐Lin Huang, Chih‐Yen Chien, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy
Ruiyun Fan, Ying Chen, Guopeng Xu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study
Airi Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2169-2178
Open Access | Times Cited: 6
Serum albumin and derived neutrophil-to-lymphocyte ratio are potential predictive biomarkers for immune checkpoint inhibitors in small cell lung cancer
Zhanpeng Kuang, Jessica Miao, Xiaoli Zhang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Prognostic value of systemic immune-inflammation index/albumin ratio for immunotherapy-treated patients receiving opioids
Lei Yan, Pan Kang, Chengsong Cao, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0305119-e0305119
Open Access | Times Cited: 2
The Systemic Inflammation Score is Associated with the Survival of Patients with Prostate Cancer
Jie Xie, Xiao Xu, Zhenjia Dong, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 963-975
Open Access | Times Cited: 6
The Naples Prognostic Score Is a Useful Tool to Assess Surgical Treatment in Non-Small Cell Lung Cancer
Stefano Elia, Alexandro Patirelis, Georgia Hardavella, et al.
Diagnostics (2023) Vol. 13, Iss. 24, pp. 3641-3641
Open Access | Times Cited: 4
Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma
Wenke Wu, Lei Miao, Zhao Lidong, et al.
Hematology (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia
Trang T. Vu, Kyeongmin Kim, Millennium Manna, et al.
Pharmacological Research (2023) Vol. 199, pp. 107048-107048
Open Access | Times Cited: 3
Risk factors for recurrence in elderly patients with stage II colorectal cancer: a multicenter retrospective study
Takuki Yagyu, Manabu Yamamoto, Akimitsu Tanio, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Prognostic Biomarkers of Systemic Inflammation in Non-Small Cell Lung Cancer: A Narrative Review of Challenges and Opportunities
Mark Stares, Leo R. Brown, Dhruv Abhi, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1508-1508
Open Access
The Predictive Value of Inflammatory Markers, Prealbumin, and Albumin in the Clinical Efficacy of PD-1 Therapy in Advanced Solid Tumor Patients
琦 陈
Advances in Clinical Medicine (2024) Vol. 14, Iss. 05, pp. 1180-1193
Closed Access
Vitamin D3 alleviates the damage caused by high-fat and maintains lipid metabolism homeostasis in hepatopancreas by promoting fatty acid β-oxidation of Portunus trituberculatus
Haiqing Cao, Qijun Luo, Shichao Xie, et al.
Aquaculture Reports (2024) Vol. 38, pp. 102320-102320
Open Access
The Geriatric Nutritional Risk Index as a prognostic factor in patients treated with immune checkpoint inhibitors with non-small-cell lung cancer
Shuai Jiang, Yang An, Fuzhi Yang, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 8, pp. 5222-5237
Open Access
Prognostic Role of Inflammatory and Nutritional Biomarkers in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Alone or in Combination with Chemotherapy as First-Line
Antonello Veccia, Mariachiara Dipasquale, Stefania Kinspergher, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3871-3871
Open Access
Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery
Zhongze Du, Hao Sun, Ruihu Zhao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
The Association Between Albumin Levels and Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Deniz Can Güven, Taha Koray Şahin, Enes Erul, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
The progresses of relevant factors on the efficacy of immune checkpoint inhibitors in the non-small cell lung cancer patients
Zhaoqing Yu, Qin Li, Guifang Yu
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100758-100758
Open Access
The Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Cancer Mortality: Insights from National Health and Nutrition Examination Survey
Xinyang Li, Meng Wu, Minxin Chen, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top